id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-276904-lmqschxy	Courcelle, Romain	Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study	2020-07-19		.txt	text/plain	1036	79	59	title: Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study The benefit of neuromuscular blocking agents (NMBA) in acute respiratory distress syndrome (ARDS) is debated [1] [2] [3] . COVID-19 ARDS appears different from classical ARDS [4] , and we aimed to describe the use of NMBA and analyze their association with day 28 outcome, in a multicentric observational prospective study (21 ICUs from Belgium and France). These latter had higher plateau pressure and rate of prone position and were more frequently in French ICUs. After propensity score matching of 206 patients, the rate and time to breathing without assistance at day 28 did not significantly differ between groups (Table 1 and Fig. 1 ). One can be surprised to observe that matched on severity, time to extubation at day 28 was similar between patients with short or long course of NMBA.	./cache/cord-276904-lmqschxy.txt	./txt/cord-276904-lmqschxy.txt